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Background. Few solid-organetransplanted patients (TP) perform regular sport activity.
Poor data are available on the safety of intense and prolonged physical exercise on this
population. The aim of the study was to evaluate kidney function parameters in a group of
TP in comparison with healthy volunteers (HV) involved in a long-distance road cycling
race: length 130 km and total uphill gradient, 1871 m.
Methods. Nineteen TP were recruited: 10 renal, 8 liver, and 1 heart and compared
with 35 HV. Renal function parameters, namely, creatinine, estimated glomerular
ﬁltration rate (eGFR), urea, uric acid, urine speciﬁc gravity, microalbuminuria,
and proteinuria were collected and their values were compared the day before the race
(T1), immediately after crossing the ﬁnish line (T2), and 18 to 24 hours after the
competition (T3).
Results. No adverse events were recorded. At baseline, TP showed lower values of eGFR
(69  22 versus 87  13 mL/min/1.73 m2), lower urine speciﬁc gravity (1015  4 versus
1019  6), and higher microalbuminuria (56  74 versus 8  15) and proteinuria values
(166  99 versus 74  44) (in mg/L). At T2 in both groups, renal function parameters
showed the same trends: decline of eGFR (54  19 versus 69  15 mL/min/1.73 m2) and
rise in protein excretion. At T3, functional parameters returned to baseline, except for
urine speciﬁc gravity values remaining stable in TP (1018  6) and growing higher in HV
(1028  4).
Conclusions. Selected and well-trained organ-transplanted patients can perform an
intensive exercise, displaying temporary modiﬁcations on kidney function parameters
comparable to healthy subjects, despite differences related to baseline clinical conditions
and pharmacological therapies.*Address correspondence to Alessandro Nanni Costa, Italian
National Transplant Centre, Istituto Superiore di Sanità, Viale
Regina Elena 299, 00161 Rome, Italy. E-mail: daniela.storani@
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teinuria during exercise are known in the general popu-
lation [3,4] but little experience is available about the
possible dose-related risk of kidney injury during sporting
activity in solid-organetransplanted patients [5]. There are
poor data about the functional kidney adaptations that
occur during intense and prolonged physical exercise in
patients receiving immunosuppressive therapy with neph-
rotoxic effects [6,7].
The aim of this paper was to contribute in describing
functional kidney changes in prolonged and intense exercise
and their possible implications in any additional risks of
kidney injury. Renal function parameters were recorded in a
group of solid-organetransplanted patients and compared
with healthy subjects involved in a long-distance road
cycling race.
METHODS
The Race
The length of the race was 130 km; total uphill gradient, 1871 m;
uphill riding, 50 km over 4 hills; downhill riding, 46 km; and ﬂat
terrain, 34 km. The temperature was 12.6 C at the start and
18.9 C at noon.
Inclusion and Exclusion Criteria
We included male subjects who usually practice cycling and
voluntarily participated in the race. The healthy volunteers (HV),
used as a control group, were amateur cyclists informed by the
organization of the study through a newsletter who reported noTable 1. Demographic His
Organ transplanted
Single kidney
Liver
Heart
Time from transplant (years)
Age (years)
BMI (kg/m2)
Immunosuppressive therapy
Tacrolimus/cyclosporine
Steroids
Mycophenolic acid
Everolimus
Hypertension therapy
Anti-hypertensive therapy
ACE inhibitors
b-Blockers
Calcium channel blocker
Workouts per week (n)
Training time for each
session (hours)
Continuous variables are expressed as means  standard deviation; categorical v
Abbreviation: BMI, body mass index.signiﬁcant clinical problem, with blood pressure (BP) values
within the normal range (<140/80 mm Hg). Solid-organe
transplanted patients (TP) were enrolled with the support of
ANED Sport (Associazione Nazionale Emodializzati, Dialisi
e Trapianto), an association involved in promoting physical
activity after transplantation. Patients were transplanted at least
1 year previously and were between 18 and 80 years of age,
with good blood pressure control (BP <140/80 mm Hg), and
they all had gone through a preliminary evaluation for their
eligibility to perform physical activity: ergometric and cardiac
function tests for assessing the likelihood of cardiovascular events
(detection of eventual silent heart disease) as previously
described [7].
Exclusion criteria included unstable cardiovascular pathology
and diabetes.Protocol
1. Baseline overall medical assessment of all the subjects, with
collection of anamnestic data, information on drug therapy,
measurement of resting heart rate and BP; questionnaire
investigating the level of training carried out throughout the
year and in preparation for the race expressed as amount of
training workouts per week and hours of training for each
session;
2. Collection of venous blood (30 mL) and urine (30 mL) samples
at time 1 (T1) (the day before the race), time 2 (T2) (immedi-
ately after crossing the ﬁnish line), and time 3 (T3) (18e24 hours
after competing);
3. Amount of ﬂuid ingestion (mL) during the race was recorded at
T2.torical Characteristics
Transplanted
Patients
(n ¼ 19)
Healthy
Volunteers
(n ¼ 35)
10 0
8
1
9.3  5.1 /
52  9 50  10
23.7  1.7 24.1  2.3
15 None
8
8
4
14 1
7 1
7
1
3.3  1.7 2.8  1.1
2.8  0.8 2.8  0.8
ariables as absolute numbers.
Table 2. Baseline Renal Function Results
Transplanted Patients (n ¼ 19) Healthy Volunteers (n ¼ 35) P Value
Creatinine (mg/dL) 1.08  0.36 0.93  0.14 NS
eGFR (MDRD) (mL/min/1.73 m2) 69  22 87  13 .01*
Urea (mg/dL) 47  14 38  8 .03*
Uric acid (mg/dL) 5.8  1.3 4.7  0.9 .01*
Urine speciﬁc gravity (densimetry) 1015  4 1019  6 .01*
Microalbuminuria (mg/L) 56  74 8  15 <.001*
Proteinuria (mg/L) 166  99 74  44 <.001*
Data are expressed as means  standard deviation.
Abbreviations: NS, not statistically signiﬁcant; eGFR (MDRD), estimated glomerular ﬁltration rate calculated from serum creatinine using the Modiﬁcation of Diet in
Renal Disease Study equation.
*P < .005.
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T2 and T3.
Renal Function Parameters
1. In blood samples: creatinine (mg/dL) with Jaffè method,
estimated glomerular ﬁltration rate (eGFR) with Modiﬁcation
of Diet in Renal Diseases formula (isotope dilution mass
spectrometry method, mass spectrometry isotope dilution
calibrated) in mL/min/1.73 m2, urea (mg/dL) with urease and
glutamate dehydrogenase, and uric acid (mg/dL) with enzy-
matic colorimetric test.
2. In urine samples: urine speciﬁc gravity (densitometry),
microalbuminuria (mg/L) (nephelometry), and proteinuria
(mg/1000 mL) (turbidimetry).
The protocol was approved by an ethics committee, and
informed consent was obtained from all the patients.
Statistical Analysis
Data are presented as mean  standard deviation. After verifying
the assumptions of normality and homoscedasticity, differences
between TP and HV were analyzed by means of Mann-Whitney U
test or t test according to the type of the data distribution. One-way
analysis of variance for independent samples was used to compare
the mean values for the quantity of training questionnaire and the
ﬂuid ingestion during the competition between TP and HV groups.
Signiﬁcance was set at P less than .05. Statistical analyses were
carried out with the use of software R, version 3.0.3.Table 3. Renal Function Blood
Creatinine (mg/dL) eGFR (mL/min/1.7
Transplanted patients (n ¼ 19)
T1 1.08  0.36 69  22
T2 1.35  0.46 54  19
T3 1.20  0.40 68  27
Healthy volunteers (n ¼ 35)
T1 0.93  0.14 87  13
T2 1.16  0.22 69  15
T3 1.00  0.14 84  14
Data are expressed as media  standard deviation.
Abbreviations: eGFR, estimated glomerular ﬁltration rate; T1, the day before the
competition.RESULTS
We recruited 19 TP: 10 renal, 8 liver, 1 heart, and 35 HV as
control a group. All the participants completed the race. No
adverse events were recorded in either group during or after
the race at T2 and T3. The race time was within a range
from 4 hours, 37 minutes, to 10 hours, with no signiﬁcant
differences between the two groups. The amount of ﬂuid
ingestion during the race was comparable between the
groups: HV, 2533  1067 versus TP, 1957  652 mL at T2.Baseline
The characteristics of the study population at baseline are
reported in Tables 1 and 2. TP and HV were similar for age
(TP, 52  9 versus HV, 50  10 years) and quantity of
training expressed as amount of training workouts per week
(TP, 3.3  1.7 versus HV, 2.8  1.1) and hours of training
for each session. TP had more need for antihypertensive
therapy (TP, 14/19 versus HV, 1/35 subjects), and inhibitors
of the renin-angiotensin system were used by 7 of 19 TP and
1 of 35 HV subjects. TP were also receiving immunosup-
pressive therapy, 15 of them with calcineurin inhibitors,
which was absent in the HV group. TP showed signiﬁcantly
lower renal function parameters at baseline that was
detected by eGFR values (TP 69  22 versus HV 87 
13 mL/min/1.73 m2, P ¼ .01) and altered values of uric acid,Values at T1, T2, and T3
3 m2) Urea (mg/dL) Uric Acid (mg/dL)
47  14 5.8  1.3
66  17 7.2  2.1
62  17 6.8  2.1
38  8 4.7  0.9
61  11 6.9  1.5
55  8 6.0  0.9
race; T2, immediately after crossing the ﬁnish line; T3, 18 to 24 hours after
Table 4. Renal Function Urine Parameters at T1, T2, and T3
Urine Speciﬁc
Gravity
(densimetry) Microalbuminuria (mg/L) Proteinuria (mg/L)
Transplanted patients (n ¼ 19)
T1 1019  6 8  15 74  44
T2 1021  6 39  48 133  83
T3 1028  4 13  24 103  49
Healthy volunteers (n ¼ 35)
T1 1015  4 56  74 166  99
T2 1017  5 259  324 420  384
T3 1018  6 41  59 141  130
Data are expressed as means  standard deviation.
Abbreviations: T1, the day before the race; T2, immediately after crossing the ﬁnish line; T3, 18 to 24 hours after competition.
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sthenuria, as shown in Table 2.
Trends in Renal Parameters
The changes at T2 were similar in the 2 groups, with an
increase of creatinine, uric acid, urea, urinary protein
excretion, and urine speciﬁc gravity and a signiﬁcant
decrease of eGFR. At T3, the values of creatinine, eGFR,
microalbuminuria, and proteinuria returned to baseline
values in both groups, whereas urea and uric acid values
remained higher than the average. Percentage changes from
baseline and at T2 and T3 on creatinine, eGFR, uric acid,
urea, microalbuminuria, and proteinuria were comparable
between groups. At T3, urine speciﬁc gravity values had a
different trend: in TP it remained stable, whereas in the HV
it further increased (Tables 3 and 4).DISCUSSION
Physical activity is an important tool for cardiovascular
disease prevention in the general population [8]; similar
data are also emerging in transplant recipients [9]. In these
patients, sport activity can facilitate a full social reintegra-
tion and improve the perception of well-being [10,11].
The results of this study suggest that organ-transplanted
patients with no cardiovascular contraindications, well-
trained and capable to keep a hydration status, were able
to complete the route without adverse events.
In our population, TP had a baseline renal impairment
(single kidney transplant or calcineurin inhibitor therapy)
that was not aggravated by the intensive exercise in the short
period. During exercise, trends in blood and urine param-
eters in TP were fully comparable to HV: they temporarily
worsened at T2, due to the known modiﬁcations occurring
in intense exercise, and returned to baseline values at T3, in
accord with physiological ﬁndings in the healthy sporting
population [4,12].
In our previous experience (unpublished data), we
collected data of microalbuminuria and proteinuria in
patients with solid-organ transplant who practiced sportsactivities for at least 3 years of recording stability over time
from baseline.
A special note is deserved by the trends in urine speciﬁc
gravity; this is the only parameter in which TP differ from
HV: in the TP group, kidney function seems to fail in
concentrating urine during the race (at T2), and the dif-
ference in urine concentration is, once again, more evident
18 to 24 hours after the race (at T3). This is feasibly due to
tubular impairment and may be affected by immunosup-
pressive drugs: ﬂuid intake was comparable between the
groups during the race, but ﬂuid ingestion between T2 and
T3 was not recorded.CONCLUSIONS
Well-trained TP with no cardiovascular contraindications
can safely participate in a long-distance road cycling race
without acute signs of kidney damage.
Our data do not reveal contraindications to sports
regarding the preservation of renal function, but this is one
of the preliminary studies. Further long-term investigations
on larger populations are needed to conﬁrm the safety of
the sport activity.REFERENCES
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